Lillian Smith

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Lillian Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lillian Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. VP, Corporate Counsel Common Stock 140,390 $445,654 $3.17 01 Apr 2023 Direct

Insider Reports Filed by Lillian Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 01 Apr 2023 1 $0 4 VP, Corporate Counsel 05 Apr 2023, 18:43
ALLO Allogene Therapeutics, Inc. 01 Apr 2023 0 $0 3 VP, Corporate Counsel 05 Apr 2023, 18:38